Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning

N/ARecruitingNCT07193069

Centre Hospitalier de Saint-Denis50 enrolled

Overview

This study looks at patients admitted to intensive care for drug poisoning involving metformin, a common diabetes medication. Researchers will compare two groups: patients who overdosed on metformin alone and those who took both metformin and dapagliflozin, another diabetes drug. The goal is to find clinical or laboratory signs that could help doctors quickly recognize a dapagliflozin overdose in this context, which could improve treatment and patient outcomes.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Drug Overdose Metformin Dapagliflozin Lactic Acidosis Diabetic Ketoacidosis Intensive Care Units

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adults aged 18 years or older * Admission to an intensive care unit (ICU) due to acute drug poisoning * Documented exposure to either: * Metformin alone * Metformin in combination with dapagliflozin Exclusion Criteria: * Patients under 18 years of age * No exposure to metformin * Exposure to dapagliflozin without metformin

Outcomes

Primary Outcomes

Identification of clinical and biological differences between patients admitted to intensive care for metformin overdose alone versus those with combined metformin and dapagliflozin overdose.

Time frame: 10 years